Chemo Compounding HD drugs - East Orange NJ

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 issued a Special Notice of Intent to Sole Source chemotherapy compounding services to OPTUM PHARMACY 801, INC., with a capability statement deadline of September 9, 2026 at 10:00 AM Eastern Standard Time. The VA intends to award a Firm Fixed Price sole-source contract for preparation of approximately 30 chemotherapy drugs and related infusion supplies, including PACLITAXEL, DOCETAXEL, CARBOPLATIN, CISPLATIN, IRINOTECAN, and FLUOROURACIL, with associated delivery equipment such as pumps, syringes, extension sets, and solutions. Performance is at the NJHCS East Orange, NJ Campus. The contractor must prepare prescriptions electronically ordered by credentialled VA providers and verified by VA pharmacists, with prescriptions faxed by 11:30 AM the day prior to treatment and delivery by 8:00 AM on the treatment date. Work must comply with USP 797 and USP 800 standards, FDA insanitary guidelines, and aseptic technique requirements. Interested sources may submit capability statements to Morgan.Weeks1@va.gov; the Government reserves discretion regarding whether to compete the contract based on responses received. NAICS 325412; PSC 6505. Solicitation 36C24226Q0844; contracting office James J. Peters VA Medical Center, Bronx, NY.